Opportunity speculation can be captured in a spreadsheet, however, the path to commercial viability is determined in the real world by users, payers, clinicians and physicians. And while a good pitch is necessary to create interest for investment, it is validating the path to commercial viability that secures the investment.

RQR offers direct funding for early stage companies based on commercial viability, strategic partners and liquidation time horizon. In addition, we advise entrepreneurs on potential sources of non-dilutive funding.

We lead life science entrepreneurs with a holistic view of their business, using comprehensive real market knowledge, behind-the-scenes access and unique funding sources to attain commercial viability.

Find out more about RQR services:

What we're actually embarking on, trying to enter the American market, is such an unnerving experience and the acedemy setup has just been wonderful. We take back so much knowledge, so much insight, and a whole network of very good people.

Anita Moe Larsen | Head of Communication | Norway Health Tech

Things are different in the US and we need people that actually have done this before and know the American system. We cannot do this ourselves.

Klaus Klausen Espedal, CMO | Independence Gear AS | Norway